Multi-centre, double-blinded, randomised controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery.

Eshan Senanayake, Neil Howell, Aaron Ranasinghe, Nigel Edward Drury, Nick Freemantle, Michael P. Frenneaux, T Oelofse, David H. Green, Ian C. Wilson, Stephen J. Rooney, Jorge Mascaro, Timothy R. Graham, Sunil Bhudia, Michael E. Lewis, Domenico Pagano

Research output: Contribution to conference (unpublished)Abstractpeer-review

Original languageEnglish
Publication statusPublished - Mar 2014
EventSociety for Cardiothoracic Surgery Annual Meeting 2014 - Edinburgh, United Kingdom
Duration: 16 Mar 2014 → …


ConferenceSociety for Cardiothoracic Surgery Annual Meeting 2014
Abbreviated titleSCTS 2014
Country/TerritoryUnited Kingdom
Period16/03/14 → …

Cite this